Mirikizumab, CAS [[1884201-71-1]]

Produktübersicht

• Artikelname: Mirikizumab, CAS [[1884201-71-1]]
• Artikelnummer: TGM-T77088
• Hersteller Artikelnummer: T77088
• Alternativnummer: TGM-T77088-1MG,TGM-T77088-5MG,TGM-T77088-10MG,TGM-T77088-25MG,TGM-T77088-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: LY3074828 , LY 3074828

Produktbeschreibung

Mirikizumab (LY3074828) is a humanized monoclonal antibody targeting the p19 subunit of interleukin-23 (IL-23), modulating immune response by inhibiting IL-23 binding to IL-23R, used in studies of ulcerative colitis.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1884201-71-1]
• Target-Kategorie: Interleukin|||IL Receptor